Iran faces medicine shortages and inflation
Iran is facing a severe shortage of medicines due to the blockade and U.S. sanctions, which have negatively impacted the pharmaceutical sector, heavily reliant on imports of raw materials. Maritime and air shipping restrictions have led to shortages of certain drugs, with reports indicating that prices for some medicines have increased by more than threefold, exacerbating patients' suffering and affecting hospitals and pharmacies' ability to meet demand. Although local production accounts for over 80%, sanctions weaken the sector because of its dependence on importing raw materials. Additionally, currency depreciation and declining value have led to higher inflation and rising living costs, further increasing the financial burdens on citizens.
Notice: This Is an AI-Generated Summary
Comments (0)